chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD; the vial was initially stored in the refrigerator on 23-Dec-2022, Dose administered after 30-day Use By Date; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 23-Dec-2022, Dose administered after 30-day Use By Date) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 23-Dec-2022, Dose administered after 30-day Use By Date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 23-Dec-2022, Dose administered after 30-day Use By Date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 23-Dec-2022, Dose administered after 30-day Use By Date).    No concomitant medication were reported.  Vial size was 0.4 ml per vial. The vial was initially stored in the refrigerator on 23-Dec-2022. Dates of administration of vaccine were 26-Jan-2023, 27-Jan-2023, 30-Jan-2023, 31-Jan-2023, 2-Feb-2023, 6-Feb-2023, 8-Feb-2023, 10-Feb-2023, 13-Feb-2023, 14-Feb-2023, 16-Feb-2023, 17-Feb-2023, 21-Feb-2023. The vial did not undergo any temperature excursions. No treatment information was provided by the reporter.  This case is of patient 16 out of 42 patients, as described by the reporer.   This case was linked to US-MODERNATX, INC.-MOD-2023-718298 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-718298:Master case
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD; The vial was initially stored in the refrigerator on 23-Dec-2022; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 23-Dec-2022).    Concomitant medication was not provided.  It was reported that the vial size was 0.4 ml per vial. The vial was initially stored in refrigerator on 23-Dec-2022. The vial did not undergo any temperature excursion. Treatment information was not provided.  This case contains information for the 36th patient out of 42 pediatric patients as described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-718298 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-718298:Master case
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: The vial was initially stored in refrigerator on 27-Feb-2023, BUD date was 29-Mar-2023 and was administered on 03-Apr-2023; No adverse event; Adult patient received expired Bivalent Moderna COVID-19 vaccine, after 30-day Use By Date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Adult patient received expired Bivalent Moderna COVID-19 vaccine, after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 27-Feb-2023, BUD date was 29-Mar-2023 and was administered on 03-Apr-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 066H22A) for COVID-19 prophylaxis.   No Medical History information was reported.    On 03-Apr-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 03-Apr-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Adult patient received expired Bivalent Moderna COVID-19 vaccine, after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 27-Feb-2023, BUD date was 29-Mar-2023 and was administered on 03-Apr-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Adult patient received expired Bivalent Moderna COVID-19 vaccine, after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 27-Feb-2023, BUD date was 29-Mar-2023 and was administered on 03-Apr-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Adult patient received expired Bivalent Moderna COVID-19 vaccine, after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 27-Feb-2023, BUD date was 29-Mar-2023 and was administered on 03-Apr-2023).    No concomitant information was reported.  Vial size was reported as 2.5 mL. Vial did not underwent any temperature excursions.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-718354 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-718354:same reporter
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD; The vial was initially stored in the refrigerator on 23-Dec-2022; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 Vaccine.     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 23-Dec-2022).    No concomitant medications were provided. It was reported that total 42 patients were affected. The vial size was 0.4 ml per vial . The vial was initially stored in the refrigerator on 23-Dec-2022. The vaccines were administered on 26-Jan-2023, 27-Jan-2023, 30-Jan-2023, 31-Jan-2023 ,02-Feb-2023, 06-Feb-2023, 08-Feb-2023, 10-Feb-2023, 13-Feb-2023, 14-Feb-2023, 16-Feb-2023, 17-Feb-2023, 21-Feb-2023. The vial did not undergo any temperature excursions. No treatment medication was provided. This case contains information for the 5th of 42 child patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-718298 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-718298:Master case
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Patient received pediatric 6m-5y vaccine after the BUD; Vial was initially stored in the refrigerator on 23-Dec-2023 and was administered after BUD; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received pediatric 6m-5y vaccine after the BUD), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 23-Dec-2023 and was administered after BUD) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received pediatric 6m-5y vaccine after the BUD), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 23-Dec-2023 and was administered after BUD) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received pediatric 6m-5y vaccine after the BUD), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 23-Dec-2023 and was administered after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received pediatric 6m-5y vaccine after the BUD) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 23-Dec-2023 and was administered after BUD).    No concomitant medications were reported.  Total 42 Dose were administered after 30-day Use By Date. Vaccine was administrated on 26-Jan-2023, 27-Jan-2023, 30-Jan2023, 31-Jan2023, 2-Feb-2023, 6-Feb-2023,8-Feb-2023, 10-Feb-2023, 13-Feb-2023, 14-Feb-2023, 16-Feb-2023, 17-Feb-2023, 21-Feb-2023. Vial size was reported was 0.4 ml per vial. Vial did not undergo any temperature excursions. No treatment information was provided.  This case was reported for patient 34 of 42 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-718298 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-718298:Master case
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Patient received vaccine after the BUD; Vaccine stored in refrigerator on 23-Dec-2022; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after the BUD), PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after the BUD), PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after the BUD), PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received vaccine after the BUD) and PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 23-Dec-2022).    No concomitant medications were reported.  Vial size was reported as.4 ml per vial. The vial was initially stored in the refrigerator 23-Dec-2022. The vial did not undergo any temperature excursions. The patient received vaccines on 26-Jan-2023, 27-Jan-2023, 30-Jan-2023, 31-Jan-2023, 2-Feb-2023, 6-Feb-2023, 8-Feb-2023, 10-Feb-2023, 13-Feb-2023, 14-Feb-2023, 16-Feb-2023, 17Feb2023 and 21-Feb-2023.  No treatment medications were reported.  This case contains information for the 15th of 42th patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-718298 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-718298:Master case
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD; The vial was initially stored in the refrigerator on 23-Dec-2022; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 23-Dec-2022).    Concomitant medication was not provided.  It was reported that the vial size was 0.4 ml per vial. The vial was initially stored in refrigerator on 23-Dec-2022. The vial did not undergo any temperature excursion. Treatment information was not provided.  This case contains information for the 25th patient out of 42 pediatric patients as described by the reporter   This case was linked to US-MODERNATX, INC.-MOD-2023-718298 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-718298:Master case
Age: 40.0
Sex: M
Vaccine: COVID19-2
Symptoms: Urticaria chronic
Clinical narrative: chronic urticaria (hives); This spontaneous case was reported by a patient and describes the occurrence of URTICARIA CHRONIC (chronic urticaria (hives)) in a 40-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA CHRONIC (chronic urticaria (hives)). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC SUMITOMO) at a dose of 40 milligram once a day; FAMOTIDINE (PEPCID AC) at a dose of 40 milligram once a day and HYDROXYZINE at a dose of 10 milligram once a day. At the time of the report, URTICARIA CHRONIC (chronic urticaria (hives)) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered URTICARIA CHRONIC (chronic urticaria (hives)) to be related.    Concomitant medication was not reported.  Patient had severe extended long-term reaction to the bivalent booster (4th shot total) and was wondering if they were studying fold like (hives and dermatographia starting almost 2 weeks after the shot). So far, the only treatment patient had been able to get steroids and antihistamine but there seems to be no end in sight to the symptoms. Patient went to the doctor, the allergist said patient had chronic urticaria (hives) from immune response to the vaccine. Patient had additional blood work done at this time but will most likely have to go in a once-a-month injection to battle the symptoms for 6 months to a year. Blood work results are not available. Patient had never got COVID. Just his immune system was in overdrive. Patient had to take 4/10 mg Zyrtec, 2/20mg Pepsid ac and 1/10mg Hydroxyzine a day to keep the symptoms at bay.
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD; gave some pediatric 6m-5y after the BUD, the vial was initially stored in the refrigerator on 23-Dec-2022; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (gave some pediatric 6m-5y after the BUD, the vial was initially stored in the refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (gave some pediatric 6m-5y after the BUD, the vial was initially stored in the refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (gave some pediatric 6m-5y after the BUD, the vial was initially stored in the refrigerator on 23-Dec-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD) and PRODUCT STORAGE ERROR (gave some pediatric 6m-5y after the BUD, the vial was initially stored in the refrigerator on 23-Dec-2022).    No concomitant medication were reported.  Vial size was 0.4 ml per vial. The vial was initially stored in the refrigerator on 23-Dec-2022.  Dates of administration of vaccine were 26-Jan-2023, 27-Jan-2023, 30-Jan-2023, 31-Jan-2023, 2-Feb-2023, 6-Feb-2023, 8-Feb-2023, 10-Feb-2023, 13-Feb-2023, 14-Feb-2023, 16-Feb-2023, 17-Feb-2023, 21-Feb-2023. The vial did not undergo any temperature excursions. No treatment information was provided by the reporter.  This case is of patient 32 out of 42 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-718298 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-718298:Master case
Age: 0.5
Sex: F
Vaccine: PNC13
Symptoms: Pyrexia, Vaccination site erythema
Clinical narrative: Fever. Redness at vaccination site.
Age: 64.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Anxiety, Back pain, Depression, Fatigue, Insomnia
Clinical narrative: The following symptoms have gotten worse after dose 5; insomnia, mild depression, panic attacks and anxiety with irritability. Lower back pain and generalized fatigue, body aches and stiffness have gotten worse. I noticed this for certain in December of 2022, but it had been gradual. I contacted the doctor on March 30, 2023 regarding these symptoms and I was prescribed Propranolol and Lithium Carbonate and Strattera.
Age: 64.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Irritability, Musculoskeletal stiffness, Pain, Panic attack
Clinical narrative: The following symptoms have gotten worse after dose 5; insomnia, mild depression, panic attacks and anxiety with irritability. Lower back pain and generalized fatigue, body aches and stiffness have gotten worse. I noticed this for certain in December of 2022, but it had been gradual. I contacted the doctor on March 30, 2023 regarding these symptoms and I was prescribed Propranolol and Lithium Carbonate and Strattera.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Hypotension, Loss of consciousness, Pyrexia
Clinical narrative: I tested positive for Covid-19 on January 8, 2023 I experienced a scratchy throat, fever, mild congestion. I was prescribed Paxlovid for my symptoms after 2-3 weeks my congestion gotten worse. Then one morning I was showering and passed out. I had a cough and my blood pressure a little low with a white high blood count. I was prescribed an antibiotic for those symptoms.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive, Throat irritation, White blood cell count increased
Clinical narrative: I tested positive for Covid-19 on January 8, 2023 I experienced a scratchy throat, fever, mild congestion. I was prescribed Paxlovid for my symptoms after 2-3 weeks my congestion gotten worse. Then one morning I was showering and passed out. I had a cough and my blood pressure a little low with a white high blood count. I was prescribed an antibiotic for those symptoms.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Brain fog, COVID-19, Chest X-ray normal, Cough, Fatigue
Clinical narrative: COVID-19 positive 11/15/2022.I had a sore throat, drippy nose, fatigue, coughing and brain fog. I reached out to my PCP and was prescribed a course of Paxlovid. After completing Paxlovid I had a rebound of all my COVID-19 symptoms. I reached out again to my PCP to get medication but he did not prescribe another dose of the medication. Om 12/07 I had a follow up with my Pulmonologist she ordered an Xray to rule out Pneumonia and it was clear. I was prescribed a 3?4-day supply of prednisone to take as needed.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: COVID-19 positive 11/15/2022.I had a sore throat, drippy nose, fatigue, coughing and brain fog. I reached out to my PCP and was prescribed a course of Paxlovid. After completing Paxlovid I had a rebound of all my COVID-19 symptoms. I reached out again to my PCP to get medication but he did not prescribe another dose of the medication. Om 12/07 I had a follow up with my Pulmonologist she ordered an Xray to rule out Pneumonia and it was clear. I was prescribed a 3?4-day supply of prednisone to take as needed.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Chest X-ray, Fatigue, Malaise, Pyrexia
Clinical narrative: I had my vaccination on 09/10/2022. I started to feel unwell on 03/26/2023 with symptoms to include a fever of 102.6. I tested COVID-19 Positive on 03/27/2023. I was prescribed Paxlovid on 03/27/2023.  I presently feel fatigued but no fever.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had my vaccination on 09/10/2022. I started to feel unwell on 03/26/2023 with symptoms to include a fever of 102.6. I tested COVID-19 Positive on 03/27/2023. I was prescribed Paxlovid on 03/27/2023.  I presently feel fatigued but no fever.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaemia, Asthenia, Behaviour disorder, Blood folate, Blood iron
Clinical narrative: Fevers Weakness  Extreme Fatigue Throwing up Extreme weight loss Cognitive processes/behavior problems Anemia B12, Iron, folic acid Dystonia Had to have testing to rule out seizures  Heart murmur POTS disease Heart regurgitation
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac murmur, Cognitive disorder, Dyspnoea, Dystonia, Fatigue
Clinical narrative: Fevers Weakness  Extreme Fatigue Throwing up Extreme weight loss Cognitive processes/behavior problems Anemia B12, Iron, folic acid Dystonia Had to have testing to rule out seizures  Heart murmur POTS disease Heart regurgitation
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Haematology test, Heart valve incompetence, Laboratory test abnormal, Neurological examination, Postural orthostatic tachycardia syndrome
Clinical narrative: Fevers Weakness  Extreme Fatigue Throwing up Extreme weight loss Cognitive processes/behavior problems Anemia B12, Iron, folic acid Dystonia Had to have testing to rule out seizures  Heart murmur POTS disease Heart regurgitation
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Vitamin B12, Vomiting, Weight decreased
Clinical narrative: Fevers Weakness  Extreme Fatigue Throwing up Extreme weight loss Cognitive processes/behavior problems Anemia B12, Iron, folic acid Dystonia Had to have testing to rule out seizures  Heart murmur POTS disease Heart regurgitation
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Chest X-ray normal, Chest pain, Crying, Dyspnoea, Electrocardiogram normal
Clinical narrative: difficulty breathing, painful inspirations in throat and upper chest region. No wheezing, no nasal flaring or grunting or retractions. no cough. Upset and crying. No abd pain, nausea, vomiting or diarrhea. No rash. Stable VS, lungs clear to auscultation in all fields.  Referred to ER, mom transported her--CXR and EKG normal. No evidence of anaphylaxis. Improvement occurred ~24 hours later, burning in throat and chest improved throughout the day.
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Painful respiration, Throat irritation
Clinical narrative: difficulty breathing, painful inspirations in throat and upper chest region. No wheezing, no nasal flaring or grunting or retractions. no cough. Upset and crying. No abd pain, nausea, vomiting or diarrhea. No rash. Stable VS, lungs clear to auscultation in all fields.  Referred to ER, mom transported her--CXR and EKG normal. No evidence of anaphylaxis. Improvement occurred ~24 hours later, burning in throat and chest improved throughout the day.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE WAS ADMINISTERED ON 2/27/23 AFTER EXPIRATION DATE (2/24/23).
Age: 73.0
Sex: M
Vaccine: PNC20, VARZOS
Symptoms: Atrial fibrillation, Cellulitis, Condition aggravated, Pyrexia
Clinical narrative: patient was diagnosed with potential severe cellulites of the left arm, worsening of the Afib and fever on and off since the date of vaccine
Age: 59.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Blood calcium increased, Blood creatinine increased, Blood pressure increased, Blood test abnormal, Blood urea increased
Clinical narrative: In January, I went to my primary care physician for my normal physical and when they took my BP it was elevated 142/ 89, and I was on medication, and they asked me to come back 3 weeks later, and it was elevated even more 158/92. They added in medication. They place me on a diuretic. March 8th, I had a blood test, and my creatine/ bun was extremely high, and they stopped the diuretic. They switched out my medicine and that has leveled out except now my calcium score is high and I'm going to see an endocrinologist and they believe something with my parathyroid is off.
Age: 59.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Parathyroid disorder, Ultrasound abdomen, Ultrasound scan abnormal, Urine analysis abnormal
Clinical narrative: In January, I went to my primary care physician for my normal physical and when they took my BP it was elevated 142/ 89, and I was on medication, and they asked me to come back 3 weeks later, and it was elevated even more 158/92. They added in medication. They place me on a diuretic. March 8th, I had a blood test, and my creatine/ bun was extremely high, and they stopped the diuretic. They switched out my medicine and that has leveled out except now my calcium score is high and I'm going to see an endocrinologist and they believe something with my parathyroid is off.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Dysphonia, Headache, Pain, Pyrexia
Clinical narrative: I woke up at 4 AM on 4/4/2023 with fever (100.4), body aches (concentrated in backs of legs and lower back). When I got up from my bed, my nose started draining. I took a home antigen test and got a positive result. I took ibuprofen, because my sinus congestion gave me a little bit of a headache. I think the ibuprofen worked, because my headache didn't get any worse, and it eventually went away. Later that afternoon, I took Sudafed, which helped with my runny nose. I called my doctor's office yesterday and asked about getting Paxlovid. He told me that I would qualify to receive it on account of my age, but I first needed to come to the clinic to have my kidneys checked to ensure they were functioning properly. At the time of this writing, I am 80% better. I slept well last night, and I woke up this morning feeling pretty decent. My voice is a little hoarse, and I now feel like I just have a mild sinus infection.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Sinus congestion, Sinusitis
Clinical narrative: I woke up at 4 AM on 4/4/2023 with fever (100.4), body aches (concentrated in backs of legs and lower back). When I got up from my bed, my nose started draining. I took a home antigen test and got a positive result. I took ibuprofen, because my sinus congestion gave me a little bit of a headache. I think the ibuprofen worked, because my headache didn't get any worse, and it eventually went away. Later that afternoon, I took Sudafed, which helped with my runny nose. I called my doctor's office yesterday and asked about getting Paxlovid. He told me that I would qualify to receive it on account of my age, but I first needed to come to the clinic to have my kidneys checked to ensure they were functioning properly. At the time of this writing, I am 80% better. I slept well last night, and I woke up this morning feeling pretty decent. My voice is a little hoarse, and I now feel like I just have a mild sinus infection.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product administration error
Clinical narrative: adminitration error-expired vaccine
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE WAS ADMINISTERED ON 3/3/23 AFTER EXPIRATION DATE (2/24/23).
Age: 77.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE WAS ADMINISTERED ON 3/3/23 AFTER EXPIRATION DATE (2/24/23).
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Emphysema
Clinical narrative: I had my vaccination on 10/20/2022. In 11/2023 I had flare up of my Emphysema. I went to my physician and gave me antibiotics and prednisone. My condition did get better over time. I had surgery in 02/2023 that was scheduled prior to the flare up to treat my Emphysema.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE WAS ADMINISTERED ON 3/7/23 AFTER EXPIRATION DATE (2/24/23).
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Deep vein thrombosis, Gait disturbance, Swelling, Ultrasound scan abnormal
Clinical narrative: I was diagnosed with a Deep Vein Thrombosis. I recognized it and went to the ER. They called in an ultrasound and confirmed it. They prescribed Eliquis. I started it that day. In a follow-up with my PCP, I pointed out that the swelling had not gone down, so he set me up for another ultrasound. I could barely walk for the first week. Three months later, I'm walking fine, but the second ultrasound showed little to no improvement. Currently, the swelling has gone down considerably, and I'm on blood thinners.
Age: 60.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: COVID-19, Cough, Headache, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I have a headache, congestion, and a little bit of a cough.  My case has been very mild compared to January 2022. I contact my doctor via Telehealth.  They prescribed Paxlovid and asked me to take Valtrex, Vitamin D3, and she supported me taking Epothex Nasal Spray.
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event
Clinical narrative: THERE was no adverse reaction i called pfizer and spoke to them
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Fatigue, Headache, Increased appetite
Clinical narrative: It started out with a cold little bit of a headache runny nose and a cough and then I got worse. Incredible runny nose with green stuff, fatigue and an increase in appetite, congestion, and headache. I was just really tired. My Dr. prescribed Paxlovid and I took Ibuprofen. I was sick over 2 weeks, no trouble breathing.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Malaise, Nasal discharge discolouration, Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea
Clinical narrative: It started out with a cold little bit of a headache runny nose and a cough and then I got worse. Incredible runny nose with green stuff, fatigue and an increase in appetite, congestion, and headache. I was just really tired. My Dr. prescribed Paxlovid and I took Ibuprofen. I was sick over 2 weeks, no trouble breathing.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: It started out with a cold little bit of a headache runny nose and a cough and then I got worse. Incredible runny nose with green stuff, fatigue and an increase in appetite, congestion, and headache. I was just really tired. My Dr. prescribed Paxlovid and I took Ibuprofen. I was sick over 2 weeks, no trouble breathing.
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: VACCINE WAS ADMINISTERED ON 3/21/23 AFTER EXPIRATION DATE (2/24/23).
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy breast normal, Breast calcifications, Mammogram abnormal
Clinical narrative: I had my annual mammogram and they said it looked abnormal. My doctor ordered me a diagnostic mammogram. They said their calcifications. I also had a biopsy 03/28/2023 and the results were benign.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cardiac monitoring abnormal, Heart rate increased
Clinical narrative: I had Rapid heart rate, and its all sinus rhythm. I was treated with beta blockers and metoprolol which didn't work. I kept having pulse rates over 100bpm. The cardiologist put a monitor on my heart,  I had constant rapid heart for a week so he changed my beta blocker to nancadolol, which partially controlled my rapid pulse. I still have high heart rate but less than before.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Chills, Headache, Malaise, Pyrexia
Clinical narrative: malaise, headache, fever, chills, upset stomach
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Exposure via skin contact, Syringe issue, Underdose
Clinical narrative: While giving the injection, the vaccine leaked out due to a defective syringe. Some vaccine also sprayed down the patient's arm but she was not otherwise harmed. It is estimated that the patient received less than half of a dose.
Age: 38.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested positive for Covid-19.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: APPROXIMATELY 30 MINS TO AN HOUR AFTER VACCINATION THE PATIENT REPORTED EXPERIENCING NUMBNESS IN HER LEFT HAND, DESCRIBED AS A PINS AND NEEDLES SENSATION.
Age: 14.0
Sex: M
Vaccine: DTAP
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient is here from another country, was giving the patient vaccinations for attendance to school in this country.  Accidently gave the patient Daptacel instead of Adacel.  Patient and his parent were notified of mistake on 4/5/2023 at 17:08, no adverse reaction noted.  Manufacturer was contacted on 4/5/2023 at 13:53 and there is no reason to re-vaccinate and this vaccination should count as the Tdap dose for the patient.  Supervisor of medical employee was notified of mistake on 4/5/2023 at 17:55. Went over the standing orders for the vaccines and will verify vaccine and age for future vaccinations.
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Fatigue, Oropharyngeal pain, Pain, Vaccine breakthrough infection
Clinical narrative: I had a breakthrough case of Covid19 after the injection I felt ache, fatigue, then I contracted Covid and had sore throat was in bed a day and a half I was prescribed PAXLOVID.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Brain fog, COVID-19, Cough, Fatigue, Headache
Clinical narrative: Got COVID around 2/10/23 cough, headache, fatigue, body aches. Too Paxlovid tight away with zinc, vita c and a cough suppressant, advil. Much improved in 1 week, then spiked a fever again on 2/19/23 with snot everywhere, sneezing,  headache, horrible body aches an severe fatigue.  I was really sick all week. Returned to work on 2t27/23 and struggled with exhaustion and brain fog.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Malaise, Pain, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Got COVID around 2/10/23 cough, headache, fatigue, body aches. Too Paxlovid tight away with zinc, vita c and a cough suppressant, advil. Much improved in 1 week, then spiked a fever again on 2/19/23 with snot everywhere, sneezing,  headache, horrible body aches an severe fatigue.  I was really sick all week. Returned to work on 2t27/23 and struggled with exhaustion and brain fog.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19-2
Symptoms: Sneezing
Clinical narrative: Got COVID around 2/10/23 cough, headache, fatigue, body aches. Too Paxlovid tight away with zinc, vita c and a cough suppressant, advil. Much improved in 1 week, then spiked a fever again on 2/19/23 with snot everywhere, sneezing,  headache, horrible body aches an severe fatigue.  I was really sick all week. Returned to work on 2t27/23 and struggled with exhaustion and brain fog.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy colon normal, Chemotherapy, Colonoscopy abnormal, Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal
Clinical narrative: Developed slight bleeding from rectum in 2/2021, had Colonoscopy, removal of polyp, and biopsy , results were negative for Cancer Findings: Internal Hemmorhoids. Being treated for Internal Hemmorhoids, bleeding continued had another  Colonoscopy in 9/13/22, findings was Rectal Cancer Stage 4 with Metastases to Liver.  Rectal mass was 7.45 cm circumferential mass, there were 5 liver masses measuring 4.7 x 3.2, 3.7  x 3.4, etc.  liver masses doubled in size from 9/13/22-11/09/22,  rectal mass shrank in half after  multiple IV chemos , liver masses maintained sizes, CEA level was not improving.  Latest CT scans of Chest, Abfomen, Pelvis 0n 3/23/2023 showed the liver masses increased in size, multiple additional swollen nodules,  and lungs shows glass like opacities in apical and bases in both lungs.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Haemorrhoids, Hepatic mass, Intestinal mass, Large intestinal polypectomy, Large intestine polyp
Clinical narrative: Developed slight bleeding from rectum in 2/2021, had Colonoscopy, removal of polyp, and biopsy , results were negative for Cancer Findings: Internal Hemmorhoids. Being treated for Internal Hemmorhoids, bleeding continued had another  Colonoscopy in 9/13/22, findings was Rectal Cancer Stage 4 with Metastases to Liver.  Rectal mass was 7.45 cm circumferential mass, there were 5 liver masses measuring 4.7 x 3.2, 3.7  x 3.4, etc.  liver masses doubled in size from 9/13/22-11/09/22,  rectal mass shrank in half after  multiple IV chemos , liver masses maintained sizes, CEA level was not improving.  Latest CT scans of Chest, Abfomen, Pelvis 0n 3/23/2023 showed the liver masses increased in size, multiple additional swollen nodules,  and lungs shows glass like opacities in apical and bases in both lungs.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Lung opacity, Metastases to liver, Positron emission tomogram, Rectal cancer stage IV, Rectal haemorrhage
Clinical narrative: Developed slight bleeding from rectum in 2/2021, had Colonoscopy, removal of polyp, and biopsy , results were negative for Cancer Findings: Internal Hemmorhoids. Being treated for Internal Hemmorhoids, bleeding continued had another  Colonoscopy in 9/13/22, findings was Rectal Cancer Stage 4 with Metastases to Liver.  Rectal mass was 7.45 cm circumferential mass, there were 5 liver masses measuring 4.7 x 3.2, 3.7  x 3.4, etc.  liver masses doubled in size from 9/13/22-11/09/22,  rectal mass shrank in half after  multiple IV chemos , liver masses maintained sizes, CEA level was not improving.  Latest CT scans of Chest, Abfomen, Pelvis 0n 3/23/2023 showed the liver masses increased in size, multiple additional swollen nodules,  and lungs shows glass like opacities in apical and bases in both lungs.
Age: 60.0
Sex: F
Vaccine: TDAP
Symptoms: Contusion
Clinical narrative: Pt has bruising on her forearm, however the shot was given in the shoulder
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Immediate post-injection reaction, Vomiting
Clinical narrative: Sudden onset of vomiting lasting over 25 minutes and resolving with no further stomach issues
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Hypoaesthesia, Neuropathy peripheral, Pain, Paraesthesia
Clinical narrative: neuropathy in bottoms of both of my feet/toes- mild tingling and strong numbness are constant, slight pain sometimes off and on. Started in summer I think in July. I am not diabetic, moderately overweight (180 pds) and not an alcoholic. No known reason why this developed.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: neuropathy in bottoms of both of my feet/toes- mild tingling and strong numbness are constant, slight pain sometimes off and on. Started in summer I think in July. I am not diabetic, moderately overweight (180 pds) and not an alcoholic. No known reason why this developed.
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Arthralgia, Chest X-ray normal, Cough, Neck pain, SARS-CoV-2 test negative
Clinical narrative: Minor but cosistant dry cough, that has persusted for two months and ongoing. Unusually bothersome aches and pains in shoulders neck, other joints My doctor prescribed MethylPREDNISoline 4MG DOSPAK 21S and Abuterol Sulfate inhaler. The steroids help the joint pain right away. The Inhaler didn't do much if anything to help.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus, no treatment, still present 1 year later